Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 vaccine (mRNA-1273.815) in preventing COVID-19-related hospitalizations and medical encounters among adults in the United States: An interim analysis

Hagit Kopel, Andre B. Araujo, Alina Bogdanov, Ni Zeng, Isabelle Winer, Jessamine Winer-Jones, Tianyi Lu, Morgan A. Marks, Mac Bonafede, Van Hung Nguyen, David Martin, James A. Mansi
doi: https://doi.org/10.1101/2024.04.10.24305549

Data Availability Statement

The data that support the findings of this study were used under license from Veradigm and Komodo Health. Due to data use agreements and its proprietary nature, restrictions apply regarding the availability of the data. Further information is available from the corresponding author.

Back to top
Posted April 12, 2024.
Download PDF
Data/Code
Email
Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 vaccine (mRNA-1273.815) in preventing COVID-19-related hospitalizations and medical encounters among adults in the United States: An interim analysis
Hagit Kopel, Andre B. Araujo, Alina Bogdanov, Ni Zeng, Isabelle Winer, Jessamine Winer-Jones, Tianyi Lu, Morgan A. Marks, Mac Bonafede, Van Hung Nguyen, David Martin, James A. Mansi
medRxiv 2024.04.10.24305549; doi: https://doi.org/10.1101/2024.04.10.24305549
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area